Source: International Congress 2016 – Features and impact of comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dejana Vukovic (Belgrade, Republic of Serbia), Dejana Vukovic, Ljudmila Nagorni Obradovic. Comorbidities and body mass index in subjects with chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 637

Member's Comments

No comment yet.

Related content which might interest you: The body mass index and chronic obstructive pulmonary disease in the BOLD study Source: Annual Congress 2013 –The best abstracts in pulmonary rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2013 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Source: Eur Respir J 2003; 22: 2S-4S Year: 2003 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Visceral adiposity index in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Prospective study of body mass index and risk of adult-onset asthma or chronic obstructive pulmonary disease in women Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010